Evidence map›Paper›PMID 18278064›Full record

ArticleBritish journal of pharmacology2008

Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells.

N Farhat, C C Matouk, A M Mamarbachi, P A Marsden, B G Allen, E Thorin

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Endothelium-derived endothelin-1.Pflugers Archiv : European journal of physiology · 2010
    Review
  7. The cardiovascular physiology and pharmacology of endothelin-1.Advances in pharmacology (San Diego, Calif.) · 2010
    Review
  8. Article
  9. Endothelium in pharmacology: 30 years on.British journal of pharmacology · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

N FarhatDepartment of Biochemistry, University of Montreal, Montreal, Quebec, Canada.
C C Matouk
A M Mamarbachi
P A Marsden
B G Allen
E Thorin
Montreal Heart Institute · CASt. Michael's Hospital · CA

Funding

CIHR 64183
6 · The paper itself

Abstract

background and purposeThe factors that influence the cellular levels of endothelin-1 (ET-1) include transcription, mRNA localization, stability and translation, post-translational maturation of preproET-1 and degradation of ET-1. We investigated the regulation of ET-1 mRNA abundance by extracellular ET-1 in porcine aortic endothelial cells (PAECs). EXPERIMENTAL APPROACH: Passsage one cultures of PAECs were incubated in starving medium in the presence or absence of ET-1 and antagonists or pharmacological inhibitors. PreproET-1 mRNA, endothelin-1 promoter activity, Erk and p38 MAPK activation were determined. KEY

resultsExogenous ET-1 reduced cellular ET-1 mRNA content: a reduction of 10 000-fold was observed after 4 h. ET-1 simultaneously reduced the stability of ET-1 mRNA and increased the loading of RNA Polymerase II at the endothelin-1 promoter. In the absence of exogenous ET-1, the ETB-selective antagonist, BQ788, increased ET-1 mRNA. An ETA-selective antagonist had no effect. ET-1 mRNA returned to control levels within 24 h. Whereas activation of p38 MAPK induced by ET-1 peaked at 30 min and returned to control levels within 90 min, Erk1/2 remained active after 4 h of stimulation. Inhibition of p38 MAPK prevented the ET-1-induced decrease in ET-1 mRNA. In contrast, Erk1/2 inhibition increased ET-1 mRNA. Similarly, inhibition of receptor internalization increased ET-1 mRNA in the presence or absence of exogenous ET-1. CONCLUSIONS AND IMPLICATIONS: These results suggest that extracellular ET-1 regulates the abundance of ET-1 mRNA in PAECs, in an ETB receptor-dependent manner, by modulating both mRNA stability and transcription via mechanisms involving receptor endocytosis and both ERK and p38 MAPK pathways.

Indexed as

AnimalsAortaEndocytosisEndothelial CellsEndothelin-1Endothelium, VascularExtracellular Signal-Regulated MAP Kinasesp38 Mitogen-Activated Protein KinasesReceptor, Endothelin BRNA, MessengerRNA Polymerase IIRNA StabilitySwineTime FactorsTranscription, GeneticEndothelin-1Extracellular Signal-Regulated MAP Kinasesp38 Mitogen-Activated Protein KinasesReceptor, Endothelin BRNA, MessengerRNA Polymerase II

Identifiers

PMID18278064
PMCPMC2437912
OpenAlexW1592449849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.